References
- Sitges‐Serra A, Jaurieta E, Sitges‐Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982; 69: 147–50
- Soeters P, Ebeid A, Fischer J. Review of 404 patients with gastrointestinal fistulas: impact of parenteral nutrition. Ann Surg 1979; 190: 189–203
- Lucy M, Tadataka Y. Biochemistry and physiology of gastrointestinal somatostatine. Dig Dis Sci 1989; 34: 5S–13S
- Di Constanzo J, Cano N, Martin J, Richieri J, Mercier R, Lafille C, et al. Treatment of external gastrointestinal fistulas by a combination of TPN and somatostatin. JPEN 1987; 5: 465–70
- Ysebaert D, Van Hee R, Hubens G, Vaneerdeweg W, Schoofs E. Treatment of postoperative pancreatic and enterocutaneous fistulas with total parenteral nutrition and somatostatin. Br J Surg 1992; 79: S118
- Di Constanzo J, Cano N, Martin J. Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition. Lancet 1982; ii: 338–9
- Hild P, Dobroschke J, Aigner K, Kahle M. Adjuvante Somatostatinbehandlung bei Anastomoseninsuffizienz und intestinaler Fistelung. Forschung Klinik Therapie‐Krankenhausarzt 1983; 56: 98–104
- Jost J, Clemens M, Rühland D, Bünte H. Somatostatin bei Pankreas‐ und Dünndarmfisteln. Zentralblatt für Chirurgie 1984; 109: 527–31
- Nubiola P, Sancho J, Segura M, Badia I, Gil M, Sitges‐Serra A. Blind evaluation of the effect of octreotide, somatostatine analogue, on small bowel fistula output. Lancet 1987; ii: 672–74
- Pederzoli P, Bassi C, Falconi M, Albrigo R, Vantini I, Miccioli R. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gyn Obst 1986; 163: 428–32
- Saari A, Schröder T, Kivilaakso E, Kalima T, Lempinen M. Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition. Scand J Gastroenterol 1989; 24: 859–62
- Nubiola P, Badia J, Martinez‐Rodenas F, Gil M, Segura M, Sancho J, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half‐life somatostatin analogue SMS 201–995. Ann Surg 1989; 210: 56–8
- Spiliotis J, Vagenas K, Panagopoulos K, Kalfarentzos F. Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only. BJCP 1990; 44: 616–7
- Torres A, Landa J, Moreno‐Azcoita M, Arguello J, Silecchia G, Castro J, et al. Somatostatin in the management of gastrointestinal fistulas. Arch Surg 1992; 127: 97–9
- Meyer J, Preusser P, Bünte H. Die Bedeutung des Somatostatins fur die Senkung der peri‐ und postoperativen Komplikationenbeid der Whipple‐Operation. Zent bl Chir 1991; 116: 917–20
- Büchler M, Friess H, Klempa I, et al. The role of somatostatin analogue octreotide in the prevention of postoperative complications following pancreatic resection: results of a multicenter controlled trial. Am J Surg 1992; 163: 125–31